Brigatinib/Brigatinib (Brigatinib) price after medical insurance

Brigatinib/Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Brigatinib belongs to the kinase inhibitor class of drugs. It works by blocking the activity of an abnormal protein that sends a reproduction signal to cancer cells, which helps slow or prevent the spread of cancer cells.

Brigatinib is an oral tablet that is usually taken once daily with or without food. Take brigatinib at about the same time each day, and do not take more or less than your doctor recommends. If a patient vomits after taking brigatinib, do not take additional doses. Continue regular dosing schedule. Doctors may start patients on a low dose of brigatinib initially and increase the dose after 7 days of treatment. Your doctor may need to temporarily or permanently stop your medication or reduce the dose of brigatinib or other medications you are taking, depending on the side effects you experience during treatment.

This original drug is marketed in China as brigatinib and has entered the scope of Class B medical insurance. Specifications The price of 30mg*14 tablets*2 tablets per box may be around 8,000 yuan, which is relatively expensive. The reimbursement ratio is different in different regions. The price after reimbursement may be different. Please consult the local medical insurance bureau or hospital for details. Currently, there are relatively cheap generic brigatinib drugs on the market overseas. Their drug ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of a box of 90mg*30 tablets produced by a Bangladesh pharmaceutical factory is around 2,000 yuan (the price may fluctuate due to exchange rates).